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clinical snippets
Micropredictors 
Candidate prognostic markers 
for cutaneous B-cell lymphoma 
have not proved particularly 
useful for predicting progression 
and survival or for delineating 
subtypes. Thus, Battistella and 
colleagues examined the targets 
of the oncogenic miR-17-92 
cluster and its paralogs for asso-
ciation with lymphoma progres-
sion in 44 patients. Expression 
of miR-20a and miR-20b and 
the expression of the down-
stream PTEN mRNA were asso-
ciated with cutaneous B-cell 
lymphoma progression, where-
as high levels of miR-20a and 
miR-20b were identified as neg-
ative prognostic factors related 
to shorter disease-free and over-
all survival in the subtypes pri-
mary cutaneous follicle center 
lymphoma and primary cutane-
ous large B-cell lymphoma, leg 
type.  See page 1659 
Hair Follicle 
Homeostasis
Ceramides, which are mem-
brane components and signal-
ing facilitators, are crucial for 
skin barrier function, and loss 
of ceramide synthase 4 (CerS4) 
reportedly results in age-related 
hair loss. Peters and colleagues 
found that CerS4 is important 
for homeostasis of the pilose-
baceous unit via regulation of 
hair follicle stem/progenitor 
cells. Specifically, loss of CerS4 
in mice resulted in inappropri-
ate activation of the hair fol-
licle stem cells, driving con-
tinuous anagen of the hair fol-
licles and ultimately leading to 
exhaustion of these stem cells 
and hair loss in older mice. 
See page 1501
Regulatory Attraction
The skin of patients with the autoimmune depig-
mentation disease vitiligo exhibits a decrease in 
regulatory T cells (Tregs), despite the lack of a 
concomitant decrease in circulating Tregs. This 
decrease is in accordance with a remarkable 
reduction in the number of chemokine (C–C motif) 
ligand 22 (CCL22)–producing cells. In a mouse 
model of vitiligo, Eby and colleagues demon-
strated that DNA-based overexpression of CCL22 
in the skin induces Treg recruitment, reduces 
effector T-cell abundance and functions, and sup-
presses ongoing depigmentation during continu-
ous treatment. These results highlight the Treg che-
moattractant CCL22 as a potential therapeutic agent for vitiligo during active disease. 
 See page 1574 
From Eggplant to Acne 
To develop new classes of small-molecule treat-
ments for acne, an extremely prevalent and com-
plex disease that lacks suitable effective treat-
ment modalities, Kwon and colleagues identified 
lupeol via activity-guided purification following 
screening tests from extracts of medicinal plants, 
including Solanum melongena (eggplant). In fur-
ther study, lupeol exhibited desirable therapeutic 
effects against all major acne targets, including 
hyperseborrhea, inflammation, follicular dysker-
atosis, and Propionibacterium acnes overgrowth. Importantly, these in vitro findings 
were mirrored in treated skin tissues from acne patients, supporting the exploration of 
this small molecule for the treatment of acne. See page 1491  
Looking Closely at Epitopes
Epidermolysis bullosa acquista (EBA) is character-
ized by autoantibodies against type VII collagen 
(COL7), which is a major component of anchoring 
fibrils. EBA presents with a variety of clinical phe-
notypes, but whether these phenotypes associate 
with the presence of antibodies to different epit-
opes within the noncollagenous (NC)-1 domain 
remains unknown. Vorobyev and colleagues report 
that autoantibodies in EBA patients recognize a 
wide variety of epitopes within COL7 NC1 and 
exhibit intramolecular cross-reactivity, although no obvious correlation with clinical pre-
sentation was observed. Furthermore, all of these autoantibodies induced  subepidermal 
blisters in COL7 humanized mice, demonstrating the in vivo relevance of these 
findings. See page 1565
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